Insider · CIK 0001197233
Phoebe A Wood
Files at LEG (LEGGETT & PLATT INC), IVZ (Invesco Ltd.), PPL (PPL Corp). First filing Sep 14, 2026, latest Sep 14, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IVZ: Invesco Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Invesco Ltd. | $97k 3,000 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | PPL PPL Corp | AGrant or award Stock Unit (DDCP)derivative | +1,335 | $32.76 | $44k | 55,500 | 10 d ago |
| Sep 11, 2026 | IVZ Invesco Ltd. | SOpen-market sale Common Shares | -3,000 | $32.44 | $97k | 107,111 | 28 d ago |
| May 15, 2025 | IVZ Invesco Ltd. | AGrant or award Common Shares | +12,728 | $0.00 | $0 | 101,999 | May 19, 2025 |
| Apr 15, 2025 | LEG LEGGETT & PLATT INC | AGrant or award Common Stock | +315 | $5.34 | $1,679 | 79,549 | Apr 16, 2025 |
| Apr 1, 2025 | PPL PPL Corp | AGrant or award Stock Unit (DDCP)derivative | +1,179 | $36.06 | $42k | 45,780 | Apr 3, 2025 |
| Feb 28, 2025 | LEG LEGGETT & PLATT INC | AGrant or award Common Stock | +16,532 | $0.00 | $0 | 79,234 | Mar 3, 2025 |
| Jan 15, 2025 | LEG LEGGETT & PLATT INC | AGrant or award Common Stock | +99 | $8.58 | $847 | 62,702 | Jan 16, 2025 |
| Oct 15, 2024 | LEG LEGGETT & PLATT INC | AGrant or award Common Stock | +80 | $10.50 | $843 | 62,604 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.